PEG PROMOTED MUCOADHESIVE DRUG DELIVERY SYSTEMS

PEG促进的粘膜粘附药物递送系统

基本信息

  • 批准号:
    2750155
  • 负责人:
  • 金额:
    $ 12.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-08-01 至 2000-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: The investigators propose to develop and study the mucoadhesive behavior of hydrophilic polymer drug carriers that are modified by the addition of polyethylene glycols, as further described by their abstract: "The primary goal of bioadhesive controlled drug delivery is to localize a delivery device within the body to enhance the drug absorption process in a site-specific manner. Bioadhesion is affected by the synergistic action of the biological environment, the properties of the polymeric controlled release device, and the presence of the drug itself. The delivery site and the device designed are dictated by the drug's molecular structure and its pharmacological behavior. Recent studies in our laboratory indicate that the mucoadhesive behavior of specific hydrophilic polymer structures used as carriers for drug delivery can be improved with the addition of poly(ethylene glycol) (PEG) as an adhesion promoter. PEG chains can be added to such structures by post-reaction grafting leading to PEG-tethered hydrogels. An additional method is by loading PEG into an already swollen hydrogel structure. In the present work we develop, characterize and evaluate new drug delivery systems containing PEG." "The fracture energy required to separate layers of hydrogel films in control with mucin is investigated to evaluate the impact of promoter chain diffusion on device/mucin adhesion and to obtain molecular information on the fracture energy in drug carrier mucoadhesion. PEG is incorporated in a hydrogel and used as an adhesion promoter. The influence of PEG molecular weight and contact time on PEG diffusion across the hydrogel/mucin interface is investigated by using tensiometry and near-field FTIR microscopy. Fracture analysis provides details about the mechanism of muco-adhesion and conditions of improved adhesion. In our work, we concentrate also on the practical development of such PEG-tethered or PEG-promoted systems for transmucosal, buccal and nasal delivery systems."
描述:调查人员建议开发和研究 改性亲水聚合物药物载体的粘附性 通过添加聚乙二醇,如其进一步描述的那样 摘要: “生物黏附控制给药的主要目标是将一种 体内的给药装置,以增强药物在体内的吸收过程 特定于站点的方式。生物粘附力受以下因素的协同作用的影响 对生物环境、聚合物的性能进行控制 释放装置,以及药物本身的存在。交货地点和 设计的设备是由药物的分子结构和它的 药理行为。我们实验室最近的研究表明 特殊亲水性聚合物结构的粘附性 药物输送载体可以通过添加 聚乙二醇(PEG)作为粘合促进剂。钉住链可以是 通过反应后接枝添加到这样的结构上,从而得到聚乙二醇系留 水凝胶。另一种方法是将聚乙二醇加载到已经肿胀的 水凝胶结构。在目前的工作中,我们开发、表征和 评估含有聚乙二醇组分的新型药物输送系统。“ “将水凝胶层分开所需的断裂能 用粘蛋白进行控制以评估启动子链的影响 在设备/粘蛋白粘连上的扩散并获得关于 药物载体黏附中的断裂能。Peg并入了一个 水凝胶,用作粘合促进剂。聚乙二醇单分子的影响 聚乙二醇水凝胶/粘蛋白界面扩散的重量和接触时间 用张力计和近场傅里叶变换红外显微镜对其进行了研究。 骨折分析提供了粘连和粘连机制的详细信息 改善附着力的条件。在我们的工作中,我们还专注于 这类聚乙二醇系留或聚乙二醇化系统的实际开发 经粘膜、口腔和鼻腔给药系统。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NICHOLAS A PEPPAS其他文献

NICHOLAS A PEPPAS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NICHOLAS A PEPPAS', 18)}}的其他基金

Decoupling Hydrogel Stiffness and Diffusivity for Hematopoietic Stem Cell Culture and Differentiation
用于造血干细胞培养和分化的水凝胶刚度和扩散率的解耦
  • 批准号:
    10647478
  • 财政年份:
    2023
  • 资助金额:
    $ 12.02万
  • 项目类别:
Thermally Responsive Magnetic-Hydrogel Nanocomposites for Advanced Drug Delivery
用于先进药物输送的热响应磁水凝胶纳米复合材料
  • 批准号:
    8339884
  • 财政年份:
    2011
  • 资助金额:
    $ 12.02万
  • 项目类别:
Thermally Responsive Magnetic-Hydrogel Nanocomposites for Advanced Drug Delivery
用于先进药物输送的热响应磁水凝胶纳米复合材料
  • 批准号:
    8242598
  • 财政年份:
    2011
  • 资助金额:
    $ 12.02万
  • 项目类别:
Study of he Biophysical Mechanisms Regulating the Efficacy of Orally Administered
口服药效调节的生物物理机制研究
  • 批准号:
    7797095
  • 财政年份:
    2009
  • 资助金额:
    $ 12.02万
  • 项目类别:
Study of he Biophysical Mechanisms Regulating the Efficacy of Orally Administered
口服药效调节的生物物理机制研究
  • 批准号:
    8564198
  • 财政年份:
    2009
  • 资助金额:
    $ 12.02万
  • 项目类别:
PEG PROMOTED MUCOADHESIVE DRUG DELIVERY SYSTEMS
PEG促进的粘膜粘附药物递送系统
  • 批准号:
    6019316
  • 财政年份:
    1997
  • 资助金额:
    $ 12.02万
  • 项目类别:
PEG PROMOTED MUCOADHESIVE DRUG DELIVERY SYSTEMS
PEG促进的粘膜粘附药物递送系统
  • 批准号:
    2378414
  • 财政年份:
    1997
  • 资助金额:
    $ 12.02万
  • 项目类别:
MUCOADHESIVE POLYMERS FOR NASAL AND BUCCAL DRUG DELIVERY
用于鼻腔和口腔给药的粘膜粘附聚合物
  • 批准号:
    3304419
  • 财政年份:
    1991
  • 资助金额:
    $ 12.02万
  • 项目类别:
MUCOADHESIVE POLYMERS FOR NASAL AND BUCCAL DRUG DELIVERY
用于鼻腔和口腔给药的粘膜粘附聚合物
  • 批准号:
    3304418
  • 财政年份:
    1991
  • 资助金额:
    $ 12.02万
  • 项目类别:
MUCOADHESIVE POLYMERS FOR NASAL AND BUCCAL DRUG DELIVERY
用于鼻腔和口腔给药的粘膜粘附聚合物
  • 批准号:
    2182934
  • 财政年份:
    1991
  • 资助金额:
    $ 12.02万
  • 项目类别:

相似海外基金

Bioenergetics in Health and Diseases
健康与疾病中的生物能量学
  • 批准号:
    10609120
  • 财政年份:
    2023
  • 资助金额:
    $ 12.02万
  • 项目类别:
Control of epithelial morphology and bioenergetics by Toll receptors during dynamic tissue remodeling
动态组织重塑过程中 Toll 受体对上皮形态和生物能的控制
  • 批准号:
    10737093
  • 财政年份:
    2023
  • 资助金额:
    $ 12.02万
  • 项目类别:
Mitochondria-rich microvesicles for restoration of intracellular bioenergetics
富含线粒体的微泡用于恢复细胞内生物能
  • 批准号:
    10586699
  • 财政年份:
    2023
  • 资助金额:
    $ 12.02万
  • 项目类别:
Defining the mechanisms of MSC extracellular vesicle modulation of microglia metabolism and bioenergetics in traumatic brain injury recovery
定义MSC细胞外囊泡调节小胶质细胞代谢和生物能学在创伤性脑损伤恢复中的机制
  • 批准号:
    10719905
  • 财政年份:
    2023
  • 资助金额:
    $ 12.02万
  • 项目类别:
To everything a season: bioenergetics in seasonal environments
季节的一切:季节性环境中的生物能学
  • 批准号:
    RGPIN-2020-06705
  • 财政年份:
    2022
  • 资助金额:
    $ 12.02万
  • 项目类别:
    Discovery Grants Program - Individual
Characterizing Alzheimer's Risk in Retired Night Shift Workers: Cognitive Function, Brain Volume, and Brain Bioenergetics
退休夜班工人患阿尔茨海默病的风险特征:认知功能、脑容量和脑生物能学
  • 批准号:
    10350125
  • 财政年份:
    2022
  • 资助金额:
    $ 12.02万
  • 项目类别:
Modulating Cellular Bioenergetics to Improve Skeletal Health
调节细胞生物能量以改善骨骼健康
  • 批准号:
    10661806
  • 财政年份:
    2022
  • 资助金额:
    $ 12.02万
  • 项目类别:
Unraveling the Associations of Molecular-Genetic Bioenergetics and Chemotherapy-Induced Fatigue Symptoms in Patients with Breast Cancer
揭示乳腺癌患者分子遗传学生物能学与化疗引起的疲劳症状之间的关联
  • 批准号:
    10684326
  • 财政年份:
    2022
  • 资助金额:
    $ 12.02万
  • 项目类别:
The role of transcription factor Ying-Yang 1 in the cardiac bioenergetics regulation
转录因子Ying-Yang 1在心脏生物能调节中的作用
  • 批准号:
    10688160
  • 财政年份:
    2022
  • 资助金额:
    $ 12.02万
  • 项目类别:
Mitochondrial protein S-glutathionylation: an in-depth interrogation of the glutaredoxin-2 glutathionylome and its impact on bioenergetics and redox signaling
线粒体蛋白 S-谷胱甘肽化:对 glutaredoxin-2 谷胱甘肽组的深入研究及其对生物能学和氧化还原信号传导的影响
  • 批准号:
    RGPIN-2022-03240
  • 财政年份:
    2022
  • 资助金额:
    $ 12.02万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了